Professional Summary
Leads a multidisciplinary team of investigators focused on developing target and mechanism specific modulators of disease relevant targets. Brings > 20 years of experience in all aspects of drug discovery. Advanced multiple compounds through preclinical studies that include ADMET and PD studies. Authored > 100 peer-reviewed scientific publications and continuously supported as PI on NIH grants for nearly 2-decades. Served on numerous review panels for various funding organizations, including as a permanent member on the NIH drug discovery and molecular pharmacology (DMP) study section.
Education
BS: Madras Christian College Madras, India, 1994 (Chemistry)
MS: Indian Institute of Technology Madras, India, 1996 (Chemistry)
PhD: University of Vermont Burlington, VT, 2001 (Organic Chemistry)
Positions and Work Experience
04-01-2001 -04-30-2005 Postdoctoral Research Associate, Developed small molecule translation initiation inhibitors for cancer therapy, Harvard Medical School, Boston, MA
05-01-2005 -06-30-2009 Assistant Professor, Established a research program focused on developing small molecule inhibitors of protein-protein interactions, University of Texas Medical Branch, Galveston, TX
07-01-2009 -07-31-2025 Ruth Branham Professor, Lead multidisciplinary drug discovery teams to advance compounds through preclinical development, University of Nebraska Medical Center, Omaha NE